The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs

Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu

Open source

DOI
10.1128/mbio.01273-23
Published
2023-10-31
Container
mBio
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/mbio.01273-23,
  title = {The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs},
  author = {Yanbai Li and Shanshan Huo and Zhe Yin and Zuguang Tian and Fang Huang and Peng Liu and Yue Liu and Fei Yu},
  year = {2023},
  journal = {mBio},
  doi = {10.1128/mbio.01273-23},
  url = {https://doi.org/10.1128/mbio.01273-23}
}

RIS

TY  - JOUR
TI  - The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
AU  - Yanbai Li
AU  - Shanshan Huo
AU  - Zhe Yin
AU  - Zuguang Tian
AU  - Fang Huang
AU  - Peng Liu
AU  - Yue Liu
AU  - Fei Yu
PY  - 2023
JO  - mBio
DO  - 10.1128/mbio.01273-23
UR  - https://doi.org/10.1128/mbio.01273-23
ER  - 

APA

Li, Y., Huo, S., Yin, Z., Tian, Z., Huang, F., Liu, P., Liu, Y., & Yu, F. (2023). The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs. mBio. https://doi.org/10.1128/mbio.01273-23

Source records